News

The Phase 1 study will evaluate the safety, tolerability, pharmacokinetic profile and antiviral activity of ACH-2684. The trial aims to enroll around 78 healthy subjects and 40 HCV

With this acquisition, Abcam will enhance its manufacturing and product development capability, particularly in the exciting area of assay development. Following the acquisition, the employees of MitoSciences will

Radius products include BA058 Injection and BA058 Microneedle Patch. The BA058 Microneedle Patch uses 3M’s patented Microstructured Transdermal System microneedle technology to administer BA058 through the skin, as

Cetirizine Oral Solution is an antihistamine, indicated for the relief sneezing, runny nose, itchy, watery eyes and itchy throat or nose due to indoor and outdoor allergies and

The company has recruited around 90 patients at four sites which include Mount Sinai School of Medicine in New York City, Wake Research Associates in Raleigh, NC, Dermatology

Skystar has reported a net income of $1.93m, or $0.27 per diluted share, compared to net income of $1.1m or $0.15 per diluted share, for the same period

The active principal Proveblue is compliant with the monograph of the European pharmacopoeia and to ICH Q3A standards on impurities in new active substances. With is approval, Provepharm

ICON Cytometry Services’ full service solution allows clients to collaborate with the company at the early stages of development to create compound-specific assays. Clients work with ICON Central

INCIVEK is an oral medicine that acts directly on the hepatitis C virus protease, an enzyme essential for viral replication. The approval of INCIVEK was based on data